We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Related Reagents.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Related Reagents(ca) - List of Manufacturers, Suppliers, Companies and Products

Related Reagents Product List

1～2 item / All 2 items

Displayed results
Unitech Co., Ltd. Genome Editing CRISPR/Cas9 Special Feature

Unitech Co., Ltd. Genome Editing CRISPR/Cas9 Special Feature

A third option that changes the speed of bio-pharmaceutical research! You can use it with confidence for research purposes.

This catalog focuses on "Genome Editing CRISPR/Cas9 Special Feature" and includes various genome editing technologies. We also introduce topics such as "from monoclonal antibody production to variable region analysis and recombinant antibody production." Additionally, we provide an overview of our contract services, making it a useful reference when considering options. 【Contents (Excerpt)】 ■ Genome Editing CRISPR/Cas9 Special Feature "Mouse Edition" ■ Genome Editing CRISPR/Cas9 Special Feature "Cell Edition" ■ Variable Region Analysis, Expression Vector Construction, Recombinant Antibody Production ■ From Monoclonal Antibody Production to Recombinant Antibody Production and Expression ■ Sales of LB Agar Plates and LB Liquid Medium Production *For more details, please refer to the PDF document or feel free to contact us.

  • Cell-related contract

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Influenza virus-related reagents

Influenza virus-related reagents

Sino Biological's influenza virus research reagents

The influenza virus is an RNA virus that causes acute respiratory diseases and outbreaks in human populations due to its strong infectivity. According to the WHO, influenza results in approximately 1 billion infections and about 290,000 to 650,000 deaths worldwide each year. Vaccination is the most effective strategy to prevent influenza virus infection and its severe complications. However, the influenza virus is prone to mutation, and the circulating strains vary from year to year. Each year, vaccine manufacturers develop and produce influenza vaccines based on the strains recommended by the WHO. Our company provides comprehensive influenza vaccine development services and production solutions to vaccine manufacturers. We offer a wide range of research reagents for influenza viruses, including influenza vaccine antigens, antibody pairs, neutralizing antibodies, and kits. Additionally, we provide high-quality technical services such as kit development, antigen expression, and antibody development. These products and services are suitable for various vaccine development scenarios, including screening of vaccine candidate strains, preparation of virus seed batches, evaluation of vaccine safety and immunogenicity, and assessment of vaccine protective effects.

  • Other research reagents

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.